PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY

Blood pressure (BP) control in patients with chronic kidney disease is one of the most pressing problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients with arterial hypertension and nephropathy, provides adequate BP control and target organs protect...

Full description

Bibliographic Details
Main Authors:	O. V. Dralova, M. L. Maksimov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	chronic kidney disease hypertension combination therapy perindopril indapamide
Online Access:	https://www.rpcardio.online/jour/article/view/875

Similar Items

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency
by: S V Shiganov, et al.
Published: (2013-12-01)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension
by: T V Glukhova, et al.
Published: (2013-03-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension
by: E M Elfimova, et al.
Published: (2015-06-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE
by: O. A. Ageenkova, et al.
Published: (2016-01-01)

Perindopril - angiotensin-converting enzyme inhibitor is approved for usage
by: D A Napalkov
Published: (2014-12-01)

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment
by: E A Temnikova
Published: (2017-06-01)

Effects of fixed-dose indapamide/perindopril combination on arterial function in patients with hypertension and chronic kidney disease: key results of the CAMERTON program
by: Zh. D. Kobalava, et al.
Published: (2019-12-01)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome
by: Svetlana Igorevna Kseneva, et al.
Published: (2011-10-01)

Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice
by: Tamila Vital'evna Martynyuk, et al.
Published: (2009-03-01)

COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH
by: O. M. Drapkina
Published: (2017-05-01)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
by: A V Aksenova, et al.
Published: (2016-06-01)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
by: Aksenova A.V., et al.
Published: (2016-06-01)

Effectiveness of combination of perindopril and indapamide on ambulatory arterial stiffness index in Vietnamese patients with primary hypertension
by: Son Kim Tran, et al.
Published: (2022-09-01)

Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in healthy Chinese volunteers
by: Huitao Gao, et al.
Published: (2023-03-01)

Fixed-dose combination of amlodipine/indapamide/perindopril arginine — a rational and safe choice for blood pressure control in actual clinical setting: data of an observational program DOKAZATEL`STVO
by: J. D. Kobalava, et al.
Published: (2020-07-01)

Modern Recommendations and Real Clinical Practice: the Results of the SILA Study
by: O. A. Kislyak, et al.
Published: (2019-05-01)

Reducing cardiovascular risk in diabetes: insights from the ADVANCE study
by: Giuliano Pinna
Published: (2013-05-01)

HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association
by: - -
Published: (2009-06-01)

Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
by: Yu. A. Karpov, et al.
Published: (2020-11-01)

Combination of perindopril/indapamide in secondary prevention of stroke and other vascular events: A combined analysis of ADVANCE, PROGRESS and HYVET trials
by: Sougat Sourendra Sarkar
Published: (2011-07-01)

ADDITIONAL ANGIOPROTECTION AND METAbOLIC DISORDERS CORRECTION IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS REACHED TARGET bLOOD PRESSURE LEVELS, WITH FIxED COMbINATION OF PERINDOPRIL AND INDAPAMIDE
by: S. V. Nedogod, et al.
Published: (2018-05-01)

Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study
by: Arrigo F. G. Cicero, et al.
Published: (2021-12-01)

Effectiveness of triple fixed-dose combination in patients with inadequate blood pressure control
by: E. V. Zbyshevskaya, et al.
Published: (2022-02-01)

Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tablet
by: Jain P.S., et al.
Published: (2012-01-01)

A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form
by: Kirtan P. Patel, et al.
Published: (2020-11-01)

Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study
by: M. G. Glezer, et al.
Published: (2020-02-01)

Modern combination antihypertensive pharmacotherapy
by: O A Mubarakshina, et al.
Published: (2018-12-01)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015-09-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

EFFECTIVENESS OF PERINDOPRIL AND AMLODIPINE COMBINATION IN HYPERTENSIVES WITH COPD
by: O. N. Kryuchkova, et al.
Published: (2014-11-01)

BLOOD PRESSURE VARIABILITY AS A NEW TARGET FOR ANTIHYPERTENSIVE THERAPY: FOCUS ON THE FIXED COMBINATION OF AMLODIPINE AND PERINDOPRIL ARGININ
by: V. M. Gorbunov
Published: (2012-10-01)

THREE-COMPONENT ANTI-HYPERYTENSION THERAPY – PROSPECTS OF APPLICATION
by: I. I. CHUKAEVA, et al.
Published: (2016-12-01)

THE ALGORITHM FOR THE TREATMENT OF PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION AT THE OUTPATIENT STAGE
by: O. S. Kulbachuk, et al.
Published: (2023-03-01)

THE EVALUATION OF ANTIHYPERTENSIVE EFFICACY OF ORALLY-DISPERSING FORM OF PERINDOPRIL IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: R. A. Khokhlov, et al.
Published: (2014-12-01)

Dissolution profiles of perindopril and indapamide in their fixed-dose formulations by a new HPLC method and different mathematical approaches
by: Gumieniczek Anna, et al.
Published: (2015-09-01)

Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension
by: B G Iskenderov, et al.
Published: (2013-05-01)

ACHIEVEMENT OF ARTERIAL HYPERTENSION CONTROL VIA APPLICATION OF PERINDOPRIL ARGININE AND AMLODIPINE COMBINATION
by: O. N. Kryuchkova, et al.
Published: (2015-12-01)